Vancomycin resistant enterococci

35
Dr.T.V.Rao. MD Dr.T.V.Rao MD 1

description

Vancomycin resistant enterococci

Transcript of Vancomycin resistant enterococci

Page 1: Vancomycin resistant enterococci

Dr.T.V.Rao. MD

Dr.T.V.Rao MD 1

Page 2: Vancomycin resistant enterococci

Introduction to Enterococci

� Enterococci are gram-positive cocci which often occur in pairs (diplococci)

� Two species are common commensal organisms in the intestines of humans: E. faecalis and E. faecium

� Enterococci occur almost everywhere, including soil, food, water, plants, animals, birds, and insects they inhabit in humans and other animal's gastrointestinal tract and the female genital tract

Dr.T.V.Rao MD 2

Page 3: Vancomycin resistant enterococci

Characters of Enterococci

� Gram(+) , Catalase(-) Cocci

� Can grow in media : 6.5% sodium chloride

� E. faecalis and E. faecium (90%)

� Part of the normal bowel flora. the prominent cause of nosocomial infections.

Dr.T.V.Rao MD 3

Page 4: Vancomycin resistant enterococci

Habitat of Enterococci

� Enterococci normally inhabit the bowel. They are found in the intestine of nearly all animals, from cockroaches to humans. Enterococci are readily recovered outdoors from vegetation and surface water, probably because of contamination by animal excrement or untreated sewage . In humans, typical concentrations of enterococci in stool are up to 108 CFU per gram .

Dr.T.V.Rao MD 4

Page 5: Vancomycin resistant enterococci

�� Enterococcus species are normal flora of the intestinal tract. Enterococcus faecalis frequently causes infections within the peritoneal cavity, especially following penetrating trauma such as gunshot wounds, and surgical wounds, urinary tract infections, prostate infections, and infections of damaged or compromised skin, such as diabetic or decubitus ulcers, burns, and surgical wounds. Other opportunistic fecal streptococci include E. faecium and E. durans.

Growing Importance of Enterococci

Dr.T.V.Rao MD 5

Page 6: Vancomycin resistant enterococci

Prominent Cause of Nosocomial Infections

� The enterococci have become the second most common bacterium isolated from nosocomial urinary and wound infections, and the third most common cause of nosocomial bacteremia. Furthermore, the enterococci are among the most antibiotic resistant of all bacteria, with some isolates resistant to all known antibiotics

Dr.T.V.Rao MD 6

Page 7: Vancomycin resistant enterococci

Clinical Manifestation

� Infections with VRE do not differ from other enterococcal infections other than in their therapy.

� The most common sites of infection :

The urinary tract and bloodstream.

� In addition, enterococci may cause endocarditis due to their ability to adhere to heart valves.

� They rarely cause respiratory tract infections.

Dr.T.V.Rao MD 7

Page 8: Vancomycin resistant enterococci

GlycopeptidesMechanism of Action

� Vancomycin and teicoplanin inhibit cell wall synthesis by forming complexes with peptidyl-D-alanyl-D-alanine termini

� vanA and vanB resistance phenotypes are associated with the acquisition of gene clusters that lead to the production of peptidoglycan ending in D-alanyl-D-lactate

Dr.T.V.Rao MD 8

Page 9: Vancomycin resistant enterococci

��Vancomycin-resistant enterococci (VRE), first reported in Europe in 1988, are emerging as a global threat to public health . The incidence of VRE infection and colonization among hospitalized patients has increased rapidly in the last 7 years. From 1989, the year VRE was first identified in the United States, through 1993. Infection with VRE may be associated with increased mortality , and no effective antimicrobial therapy is available for many VRE .

Vancomycin Resistance Increases Morbidity and Mortality

Dr.T.V.Rao MD 9

Page 10: Vancomycin resistant enterococci

VRE Epidemiology� Found world-wide, but rates vary greatly

� Hospital outbreaks often involve clonal spread

� Also seen in nursing homes and long term care facilities

� In Europe, animals may be a source due to the use of the glycopeptide, avoparcin

� First described in Europe

� Primarily a nosocomial pathogen

� Alarming increase from 1989 to 1993

� intensive care units

teaching hospitals

hospitals with more than 500 beds.

Dr.T.V.Rao MD 10

Page 11: Vancomycin resistant enterococci

��Mechanism of action: Inhibits bacterial cell wall synthesis

� Spectrum of action: Gram positive organisms� Including: Listeria, Rhodococcus, Peptostreptococcus

� Bacteriostatic against enterococcus

�Mechanism of resistance: � Enterococcus: Van A – E

� Peptidoglycan precursor has decreased affinity for vancomycin – D-ala-D-ala replaced by D-ala-D-lac

Vancomycin and Development of VRE Strains

Dr.T.V.Rao MD 11

Page 12: Vancomycin resistant enterococci

��(VRE), are bacterial strains of the genus Enterococcus that are resistant to the antibiotic vancomycin. Enterococci are gram-positive coccoid-shaped bacteria found in the digestive tract of some humans. To become VRE, vancomycin-sensitive enterococci typically obtain new DNA in the form of plasmids or transposons which encode genes that confer vancomycin resistance.

Vancomycin-Resistant Enterococci

Dr.T.V.Rao MD 12

Page 13: Vancomycin resistant enterococci

vanA and vanB Phenotypes

vanA vanB

Vancomycin MIC >64 4-1024

Teicoplanin MIC 16-512 ≤≤≤≤0.5

Usual species faecium, faecalis faecium, faecalis

Acquired Yes Yes

Transferable Yes Yes

Page 14: Vancomycin resistant enterococci

MOLECULAR BASIS OF VANCOMYCIN RESISTNACE

Page 15: Vancomycin resistant enterococci

vanC, vanD, and vanE Phenotypes

vanC vanD vanE

Vancomycin

MIC2-32 128 16

Teicoplanin

MIC≤≤≤≤0.5 4.0 0.5

Usual species gallinarum,

casseliflavis,

flavescens

faecium faecalis

Acquired No Yes Yes

Transferable No No No

Page 16: Vancomycin resistant enterococci

Glycopeptide-Resistance Transposons

� In E. faecium, vanA and related genes are located on a transposon (Tn1546) which resides on a plasmid

� Resistance is associated with a number of genes (vanHAX gene cluster, vanS, vanR, vanX and vanZ)

� vanB phenotype is associated with Tn5382

Dr.T.V.Rao MD 16

Page 17: Vancomycin resistant enterococci

vanA Genes and Their Enzymatic Products (I)

�vanA protein is a ligase �produces D-ala-D-lac rather than D-ala-D-ala (vanA alone does not lead to resistance)

�vanH protein is a dehydrogenase �converts pyruvate to D-lactic acid (the source of lactate for the above reaction)

�vanX protein is D,D-dipeptidase �cleaves D-ala-D-ala

(Cetinkaya et al. 2000. Clin Micro Rev. 13: 686-707)Dr.T.V.Rao MD 17

Page 18: Vancomycin resistant enterococci

vanA Genes and Their Enzymatic Products (II)

�vanS is a sensor � detects the presence of vancomycin or some effect of it

�vanR is a regulator � may turn on vanHAX

�vanY is a carboxypeptidase � cleaves terminal D-Ala

�vanZ increases the MIC of teicoplanin � mechanism is unknown

Cetinkaya et al. 2000. Clin Micro Rev. 13: 686-707

Dr.T.V.Rao MD 18

Page 19: Vancomycin resistant enterococci

vanB Genes and Resistance

�vanB is also a ligase � involved with D-ala-D-lac production

�vanXB has dipeptidase activity� associated with high level vancomycin resistance

�vanHB, vanYbB, vanSB and vanRB genes� similar to their vanA counterparts

�Teicoplanin does not induce the synthesis of vanB proteins and cells are still susceptible

Cetinkaya et al. 2000. Clin Micro Rev. 13: 686-707

Dr.T.V.Rao MD 19

Page 20: Vancomycin resistant enterococci

vanC, vanD and vanE Resistance

� vanC ligases result in D-ala-D-ser

� net result is reduced vancomycin binding

� vanD ligase

� has some homology with other van ligases

� vanE ligase

� rare

� more closely related to vanC than the other van ligases

Dr.T.V.Rao MD 20

Page 21: Vancomycin resistant enterococci

ResultSpreading Resistance

� Enterococci that acquire the vanA phenotype are highly resistant to vancomycin and to teicoplanin

� Enterococci can pass the vanA gene cluster to S. aureus� E. faecalis rather tan E. faecium (so far)

Dr.T.V.Rao MD 21

Page 22: Vancomycin resistant enterococci

��Urinary tract infection (most common)

� Intra-abdominal and pelvic infection (also common)

� Surgical wound infection

�Bacteremia—bacteria in the blood

� Endocarditis —infection of the inner surface of the heart muscles and valves

�Neonatal sepsis —bacteria in the blood, occurring in infants

�Meningitis —infection of the membranes that surround the brain and spinal cord

Infections Caused by Vancomycin Resistant Enterococci

Dr.T.V.Rao MD 22

Page 23: Vancomycin resistant enterococci

Dr.T.V.Rao MD 23

Page 24: Vancomycin resistant enterococci

��Diagnosis requires culturing the organism. VRE is easily grown on culture plates in a laboratory. To get material to culture, a sample of the infected tissue is taken. For a wound infection, a swab is usually rubbed over the surface to get infected material. Blood is drawn and cultured to detect sepsis or endocarditis. Urine samples are taken to identify urinary infections .

Diagnosis of VRE Specimens can proceeded as per clinical

Needs

Dr.T.V.Rao MD 24

Page 25: Vancomycin resistant enterococci

Enterococci are Bile Esculin Test Positive

� Enterococci are able to grow in the presence of bile and hydrolyze the esculin; the liberated diphydroxycourmarin complexes with ferric citrate present in the media to form a dark brown/black soluble compound.

Dr.T.V.Rao MD 25

Page 26: Vancomycin resistant enterococci

Bile Esculin Test Positive for group D streptococci and enterococci

Dr.T.V.Rao MD 26

Page 27: Vancomycin resistant enterococci

Detection of Vancomycin Resistance

� Susceptibility to vancomycin was performed by Kirby-Bauer Disc Diffusion Method on Mueller Hinton Agar by using 30µg vancomycin disc . Vancomycin resistance was also determined by Vancomycin agar screen method using 6µg/ml of vancomycin incorporated in Brain Heart Infusion (BHI) agar.

Dr.T.V.Rao MD 27

Page 28: Vancomycin resistant enterococci

Detection of Vancomycin Resistance

�Minimum Inhibitory Concentration (MIC) of all the isolates were done by Macro broth dilution method, using dilutions of vancomycin ranging from 2 µg/ml to 512 µg/ml.

Dr.T.V.Rao MD 28

Page 29: Vancomycin resistant enterococci

Drug Resistance can be Established by E-Test

Dr.T.V.Rao MD 29

Page 30: Vancomycin resistant enterococci

*Chromogenic Methods in Diagnosis of VRE

�Chromogenic medium for the detection of Vancomycin Resistant Enterococcus (VRE) E. faecalis and E. faecium

� * Colorex™ Prepared Chromogenic Media by BioMed Diagnostics

Dr.T.V.Rao MD 30

Page 31: Vancomycin resistant enterococci

Genotypic Detection of VRE

�Rapid detection of vancomycin resistance by polymerase chain reaction (PCR). useful in epidemiologic studies

�PCR cant be performed directly on clinical specimens.

Dr.T.V.Rao MD 31

Page 32: Vancomycin resistant enterococci

Control and Prevention�Limiting the use of certain broad spectrum antibiotics may also lead to a decrease in the rates of VRE colonization and infection.

�One study suggested that reduction of third-generation cephalosporins with the substitution of piperacillin/tazobactam could reduce the incidence of VRE in an intensive care unit setting

Hospital Infection Control Practices Advisory Committee (HICPAC). Recommendations for preventing the spread of

vancomycin resistance. Infect Control Hosp Epidemiol 1995; 16:105Dr.T.V.Rao MD 32

Page 33: Vancomycin resistant enterococci

Control and Prevention�The CDC has recently published

recommendations for preventing the spread of vancomycin resistance

� Prudent use of vancomycin

� Education of hospital staff regarding the problem

� Rapid and accurate identification of VRE in the microbiology laboratory

� Aggressive infection control measures utilizing contact isolation and cohorting where necessary to prevent person-to-person transmission

Hospital Infection Control Practices Advisory Committee (HICPAC). Recommendations for preventing the spread of vancomycin

resistance. Infect Control Hosp Epidemiol 1995; 16:105Dr.T.V.Rao MD 33

Page 34: Vancomycin resistant enterococci

Dr.T.V.Rao MD 34

Hand Washing can Reduce the Spread of VRE

Page 35: Vancomycin resistant enterococci

��Created by Dr.T.V.Rao MD for ‘ e ‘ Learning Resources for Medical and

Paramedical Professionals in Developing World

�Email

[email protected]

Dr.T.V.Rao MD 35